ClinicalTrials.gg
WithdrawnNCT01658891Updated Jun 18, 2018

Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children

A Phase 3 interventional study of combination of beclomethasone dipropionate 50µg + formoterol fumarate 6µg and free combination of beclomethasone dipropionate 100µg + Formoterol fumarate 6µg in Asthma in Children, sponsored by Chiesi Farmaceutici S.p.A.. Withdrawn at 1 site in Denmark. Open to participants aged 5 Years to 11 Years. Per ClinicalTrials.gov, last updated 2018-06-18.

Sponsored by Chiesi Farmaceutici S.p.A. · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
5 Years to 11 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 40 studies testing beclomethasone in Asthma — none open to participants now, none under way, none of them phase 3. Beclomethasone · Asthma.

Enrollment
37th of 40
0 · median 67
Started
2014
with 2 others
Phase 3
20 of 40
none open now
Registered
21st of 40
by date
Lead sponsor
12 of 40
Chiesi Farmaceutici S.p.A.

Among the 40 studies testing beclomethasone in Asthma, this one is the 37th largest by enrollment, is one of 3 that started in 2014, is one of 20 in phase 3, and was the 21st registered.

Asthma

4,848 studies on the registry are indexed under Asthma; 605 are open to participants now.

Browse Asthma studies →

Open to participants now

None of the 40 studies testing beclomethasone in Asthma is open now. The open studies under Asthma, anywhere →

About beclomethasone

Beclomethasone: first FDA approval 1976 (VANCERIL), first EMA approval 2017. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 417 Asthma studies recruiting now, 140 (34%) set no upper age limit and 205 (49%) stop at 75 or younger; 147 take children under 18; 105 take healthy volunteers.

This study: 5 Years to 11 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 40 studies testing beclomethasone in Asthma as a file.
02

Study summary

single center, double-blind, double-dummy, 2-way cross over study in asthmatic children already treated with inhaled corticosteroids

03

Conditions studied

  • Asthma in Children

Browse trials for

04

Who can participate

Ages eligible
5 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Prepuberal male and female outpatients, ≥ 5 and \< 12 years old in Tanner stadium I according to Investigator's assessment;
  • Clinical diagnosis of mild asthma during at least two months prior to screening visit;
  • Forced Expiratory Volume during the first second () > 80% of predicted normal values at screening visit;

Exclusion criteria

Exclusion Criteria:

  • Endocrinological diseases including growth impairment or other chronic diseases;
  • Any concomitant disease requiring additional treatment with topic or systemic glucocorticosteroids;
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    CHF 1535 50/6 µg

    Drug: combination of beclomethasone dipropionate 50µg + formoterol fumarate 6µg

  • Active comparator
    beclomethasone dipropionate 100µg + Formoterol fumarate 6µg

    Drug: free combination of beclomethasone dipropionate 100µg + Formoterol fumarate 6µg

Interventions

  • Drugcombination of beclomethasone dipropionate 50µg + formoterol fumarate 6µg

    Drug pages: Beclomethasone · Formoterol

    beclomethasone dipropionate 50µg + formoterol fumarate 6µg, 2 inhalations b.i.d. for 2 weeks

  • Drugfree combination of beclomethasone dipropionate 100µg + Formoterol fumarate 6µg

    beclomethasone dipropionate 100µg, 1 inhalation b.i.d. for 2 weeks and formoterol fumarate 6µg, 2 inhalations b.i.d. for 2 weeks

06

What researchers measure

Primary outcomes

  1. Lower Leg Growth rate measured by Knemometry

    Time frame: after 2 weeks of treatment

Secondary outcomes

  1. 24-hour urinary free cortisol/creatinine levels

    Time frame: after 2 weeks of treatment

  2. Changes in pre-dose morning and evening PEF (L/min)

    Time frame: after 2 weeks of treatment

07

Study locations

1 site
  • BørneAstmaKlinikken
    Copenhagen, 2100, Denmark
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Feb 2014, a primary completion of Nov 2015 and a completion of Feb 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 3, 2012
First posted
Aug 7, 2012
Start
Feb 2014
Primary completionEst.
Nov 2015
CompletionEst.
Feb 2016
Last update
Jun 18, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 18, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01658891
Responsible party
Sponsor
First posted
Aug 7, 2012
Start date
Feb 2014
Primary completion
Nov 2015 (estimated)
Completion
Feb 2016 (estimated)
Last update
Jun 18, 2018

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Beclomethasone · Formoterol

Start the discussion